MYP_146203
Aducanumab
Immunology
▸
Immune modulation
▸
Immunomodulatory activity
not Standard
453 amino acids
-
contains X representing unresolved or non-standard residue
XVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available: incomplete physicochemical profile.
- Molecular Weight
- Not available
- Isoelectric Point (pI)
- Not available
- Net Charge (pH 7.0)
- Not available
- GRAVY Index
- Not available
- Boman Index
- Not available
- Instability Index
- Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Amino Acid Composition
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0118636
REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Immunomodulatory
Diagnostic
The terminal half life of aducanumab is 24.8 days.[L34393]
RECORD: Rec_0378200
REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Diagnostic
The terminal half life of aducanumab is 24.8 days.[L34393]